Global Patent Index - EP 3924367 A4

EP 3924367 A4 20221012 - VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) FOR BETTER WOUND HEALING THROUGH ENHANCED ANGIOGENESIS

Title (en)

VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) FOR BETTER WOUND HEALING THROUGH ENHANCED ANGIOGENESIS

Title (de)

GEFÄSSENDOTHELWACHSTUMSFAKTOR (VEGF) ZUR BESSEREN WUNDHEILUNG DURCH ERHÖHTE ANGIOGENESE

Title (fr)

FACTEUR DE CROISSANCE ENDOTHÉLIAL VASCULAIRE (VEGF) POUR UNE MEILLEURE CICATRISATION DE PLAIE PAR ANGIOGENÈSE AMÉLIORÉE

Publication

EP 3924367 A4 20221012 (EN)

Application

EP 20908461 A 20200402

Priority

  • IN 201941013671 A 20190404
  • IN 2020050321 W 20200402

Abstract (en)

[origin: WO2020202214A2] The present invention discloses and claims a functionally active peptide of VEGF of SEQUENCE ID NO.: 3 through primers for RT-PCR for cloning the c-DNA obtained from VEGF, comprising a forward primer of 28 bp under SEQUENCE ID NO.: 2 and the reverse primer under SEQUENCE ID NO.: 1 of 32 bp. In addition, the present invention discloses a process of preparation of VEGF comprising the steps of isolating the RNA of VEGF (SEQUENCE ID NO.: 3); RT-PCR of VEGF using primers of SEQUENCE ID NO.: 1 and 2, and collecting the purified c DNA; ligating the clones as obtained with the vector pTZ57R/T; preparing the competent cells; transforming the cloned cells after selecting through antibiotic resistance in vector; isolating the protein obtained; and purifying said obtained VEGF protein.

IPC 8 full level

C07K 14/515 (2006.01); A61K 39/00 (2006.01); C12N 15/11 (2006.01)

CPC (source: EP)

A61P 17/02 (2017.12); C07K 14/52 (2013.01); A61K 38/00 (2013.01)

Citation (search report)

  • [XY] US 7928061 B2 20110419 - ACHEN MARC G [AU], et al
  • [XY] YAMADA Y ET AL: "Molecular Cloning of a Novel Vascular Endothelial Growth Factor, VEGF-D", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 42, no. 3, 15 June 1997 (1997-06-15), pages 483 - 488, XP004459556, ISSN: 0888-7543, DOI: 10.1006/GENO.1997.4774
  • [XY] RISSANEN TUOMAS T ET AL: "VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses", CIRCULATION RESEARCH, AMERICAN HEART ASSOCIATION, INC, US, vol. 92, no. 10, 30 May 2003 (2003-05-30), pages 1098 - 1106, XP002491555, ISSN: 1524-4571, DOI: 10.1161/01.RES.0000073584.46059.E3
  • [XY] VEIKKOLA TANJA ET AL: "VEGFs, receptors and angiogenesis", SEMINARS IN CANCER BIOLOGY, SAUNDERS SCIENTIFIC PUBLICATIONS, PHILADELPHIA, PA, US, vol. 9, no. 3, 1 June 1999 (1999-06-01), pages 211 - 220, XP002198307, ISSN: 1044-579X, DOI: 10.1006/SCBI.1998.0091
  • [XY] ORLANDINI M ET AL: "IDENTIFICATION OF A C-FOS INDUCED GENE THAT IS RELATED TO THE PLATELET-DERIVED GROWTH FACTOR/VASCULAR ENDOTHELIAL GROWTH FACTOR FAMILY", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, vol. 93, no. 21, 15 October 1996 (1996-10-15), pages 11675 - 11680, XP002029340, ISSN: 0027-8424, DOI: 10.1073/PNAS.93.21.11675

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

WO 2020202214 A2 20201008; WO 2020202214 A3 20201203; WO 2020202214 A4 20210311; EP 3924367 A2 20211222; EP 3924367 A4 20221012

DOCDB simple family (application)

IN 2020050321 W 20200402; EP 20908461 A 20200402